ACCOUNTS - Final Accounts

Operating profit

The operating profit is stated after charging/(crediting):

Period ended
31 December

Year ended
30 June

Registered number: 02634604

GLOBAL INFUSION GROUP LTD

ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

GLOBAL INFUSION GROUP LTD

COMPANY INFORMATION

Directors	M A Laurenson
	S L May
	D Joel


Registered number	02634604


Registered office	Unit 1 Symmetry Park
	Samian Way
	Aston Clinton
	Bucks
	HP22 5WJ


Independent auditors	Barnes Roffe Audit Limited
	Chartered Accountants & Statutory Auditor
	3 Brook Business Centre
	Cowley Mill Road
	Uxbridge
	Middlesex
	UB8 2FX

GLOBAL INFUSION GROUP LTD

CONTENTS

	Page
Group strategic report	1 - 2
Directors' report	3 - 4
Independent auditors' report	5 - 9
Consolidated statement of comprehensive income	10
Consolidated statement of financial position	11 - 12
Company statement of financial position	13 - 14
Consolidated statement of changes in equity	15
Company statement of changes in equity	16
Consolidated statement of cash flows	17 - 18
Consolidated analysis of net debt	19
Notes to the financial statements	20 - 42

GLOBAL INFUSION GROUP LTD

GROUP STRATEGIC REPORT

FOR THE PERIOD ENDED 31 DECEMBER 2024

Introduction

The directors present their strategic report for the period ended 31 December 2024.
Principal Activity
The company and group’s principal activity continues to be that of caterers.

Business review and future developments

The financial period to December 2024 was in line with forecast and management expectations for both revenue and profit.
Despite the challenging economic conditions, the business continues to be profitable whilst delivering a number of successful events. Global supply chain issues and inflationary pressures are expected to remain for the foreseeable future.
The business maintains a healthy balance of activities across catering and logistics with a wide range of opportunities for the group in 2025. The group is expected to remain profitable with underlying organic growth.

Principal risks and uncertainties

The main risks facing the business are liquidity risk, credit risk, currency risk, cash flow risk. The directors have reviewed and agreed policies for managing each of these risks.
Liquidity risk
The group seeks to manage liquidity risk by ensuring that sufficient funding is available to meet future requirements. This is done using forecasting methods.
Credit risk
The group trades only with recognised, creditworthy third parties. In addition, receivable balances are monitored on an ongoing basis with the result that the company's exposure to bad debts is not significant.
Currency risk
The group makes an element of its sales and purchases in foreign currencies. The directors monitor on an ongoing basis the currency risk arising to the company and ensures that the risk remains at an acceptable level. Where possible, costs and incomes are matched in that foreign currency to minimise exchange risk with bank accounts held in many different currencies.

Financial key performance indicators

The key financial performance indicators of the group include gross profit, and turnover.
The group's turnover for the financial period was £12,877,525 (year ended 30 June 2024 - £15,708,322).
The group's gross profit margin was 25.58% (year ended 30 June 2024 - 30.69%).

Page 1

GLOBAL INFUSION GROUP LTD

GROUP STRATEGIC REPORT (CONTINUED)

FOR THE PERIOD ENDED 31 DECEMBER 2024

This report was approved by the board on 27 August 2025 and signed on its behalf.

S L May

Director

Page 2

GLOBAL INFUSION GROUP LTD

DIRECTORS' REPORT

FOR THE PERIOD ENDED 31 DECEMBER 2024

The directors present their report and the financial statements for the period ended 31 December 2024.

Directors' responsibilities statement

The directors are responsible for preparing the Group strategic report, the Directors' report and the consolidated financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and the Group and of the profit or loss of the Group for that period.

In preparing these financial statements, the directors are required to:

∙select suitable accounting policies for the Group's financial statements and then apply them consistently;

∙make judgments and accounting estimates that are reasonable and prudent;

∙state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

∙prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Group will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and the Group and to enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and the Group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Results and dividends

The profit for the period, after taxation, amounted to £262,921 (year ended 30 June 2024 - £239,167).

During the period, the company paid dividends of £Nil (year ended 30 June 2024 - £Nil).

Directors

The directors who served during the period were:

M A Laurenson

S L May

T Young (resigned 11 April 2025)

D Joel was appointed as a director on 11 April 2025.

Matters covered in the strategic report

The company has chosen, in accordance with section 414C of the Companies Act 2006, to set out financial risk management objectives and policies within the Strategic report.

Page 3

GLOBAL INFUSION GROUP LTD

DIRECTORS' REPORT (CONTINUED)

FOR THE PERIOD ENDED 31 DECEMBER 2024

Disclosure of information to auditors

Each of the persons who are directors at the time when this Directors' report is approved has confirmed that:

∙so far as the director is aware, there is no relevant audit information of which the Company and the Group's auditors are unaware, and

∙the director has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company and the Group's auditors are aware of that information.

Post balance sheet events

There have been no subsequent events that require disclosure or adjustment to the financial statements.

Auditors

After the year end, Barnes Roffe LLP resigned as auditors due to the transfer of its audit business and its
successor, Barnes Roffe Audit Limited, was appointed by the directors under section 485 of the Companies Act
2006.

This report was approved by the board on 27 August 2025 and signed on its behalf.

S L May

Director

Page 4

GLOBAL INFUSION GROUP LTD

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF GLOBAL INFUSION GROUP LTD

Opinion

We have audited the financial statements of Global Infusion Group Ltd (the 'parent Company') and its subsidiaries (the 'Group') for the period ended 31 December 2024, which comprise the Consolidated statement of comprehensive income, the Consolidated Statement of Financial Position, the Company Statement of Financial Position, the Consolidated Statement of Changes in Equity, the Consolidated Statement of Cash Flows, the Company Statement of Changes in Equity and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

∙give a true and fair view of the state of the Group's and of the parent Company's affairs as at 31 December 2024 and of the Group's profit for the period then ended;

∙have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

∙have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the Group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Group's or the parent Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Page 5

GLOBAL INFUSION GROUP LTD

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF GLOBAL INFUSION GROUP LTD (CONTINUED)

Other information

The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' report thereon. The directors are responsible for the other information contained within the Annual Report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinion on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

∙the information given in the Group strategic report and the Directors' report for the financial period for which the financial statements are prepared is consistent with the financial statements; and

∙the Group strategic report and the Directors' report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the Group and the parent Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group strategic report or the Directors' report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

∙adequate accounting records have not been kept by the parent Company, or returns adequate for our audit have not been received from branches not visited by us; or

∙the parent Company financial statements are not in agreement with the accounting records and returns; or

∙certain disclosures of directors' remuneration specified by law are not made; or

∙we have not received all the information and explanations we require for our audit.

Page 6

GLOBAL INFUSION GROUP LTD

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF GLOBAL INFUSION GROUP LTD (CONTINUED)

Responsibilities of directors

As explained more fully in the Directors' responsibilities statement set out on page 3, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the Group's and the parent Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Group or the parent Company or to cease operations, or have no realistic alternative but to do so.
Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these Group financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with law and regulations, was as follows:

∙The engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;

∙We identified the laws and regulations applicable to the Company through discussion with directors and other management, and from our commercial knowledge and experience of the relevant sector;

∙The specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the Company, are as follows:
i) Companies Act 2006.
ii) FRS 102.
iii) Employment legislation.
iv) Tax legislation.
v) Health & safety

∙We assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and reviewing supporting evidence where applicable; and

∙Laws and regulations were communicated within the audit team at the planning meeting, and during the audit as any further laws and regulation were identified. The audit team remained alert to instances of noncompliance throughout the audit.

Page 7

GLOBAL INFUSION GROUP LTD

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF GLOBAL INFUSION GROUP LTD (CONTINUED)

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur by:

∙Making enquiries of management as to where they consider there was susceptibility to fraud and their knowledge of actual suspected and alleged fraud;

∙Considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations;

∙Reviewing the financial statements and testing the disclosures against supporting documentation;

∙Performing analytical procedures to identify any unusual or unexpected trends or anomalies;

∙Inspecting and testing journal entries to identify unusual or unexpected transactions;

∙Assessing whether judgement and assumptions made in determining significant accounting estimates, were indicative of management bias; and

∙Investigating the rationale behind significant transactions, or transactions that are unusual or outside the company’s usual course of business.

The areas that we identified as being susceptible to misstatement through fraud were:

∙Management bias in the estimates and judgements made;

∙Management override of controls; and

∙Posting of unusual journals or transactions

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditors' report.

Page 8

GLOBAL INFUSION GROUP LTD

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF GLOBAL INFUSION GROUP LTD (CONTINUED)

Use of our report

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.

Mark Hancock FCA (Senior statutory auditor)

for and on behalf of

Barnes Roffe Audit Limited

Chartered Accountants & Statutory Auditor

3 Brook Business Centre

Cowley Mill Road

Uxbridge

Middlesex

UB8 2FX

29 August 2025

Page 9

GLOBAL INFUSION GROUP LTD

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE PERIOD ENDED 31 DECEMBER 2024

	Period ended 31 December	Year ended 30 June
	2024	2024
Note	£	£


Turnover	4	12,877,525	15,708,322
Cost of sales		(9,583,498)	(10,887,123)
Gross profit		3,294,027	4,821,199
Administrative expenses		(2,847,334)	(4,324,902)
Operating profit	5	446,693	496,297
Interest receivable and similar income	9	5,287	11,723
Interest payable and similar expenses	10	(34,190)	(78,967)
Profit before taxation		417,790	429,053
Tax on profit	11	(154,869)	(189,886)
Profit for the financial period/year		262,921	239,167


Movement on foreign exchange reserve	(35,122)	11,314
Other comprehensive income for the period/year	(35,122)	11,314
Total comprehensive income for the period/year	227,799	250,481

Profit for the period attributable to:
Owners of the parent Company	262,921	239,167
	262,921	239,167

The notes on pages 20 to 42 form part of these financial statements.

Page 10

GLOBAL INFUSION GROUP LTD

REGISTERED NUMBER: 02634604

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 31 DECEMBER 2024

		31 December		30 June
		2024		2024
Note	£	£	£	£

Fixed assets
Intangible assets	12		15,746		18,711
Tangible assets	13		1,851,602		1,930,503
			1,867,348		1,949,214
Current assets
Stocks	15	-		79,174
Debtors: amounts falling due within one year	16	3,526,338		4,448,177
Cash at bank and in hand	17	2,248,510		2,214,594
		5,774,848		6,741,945
Creditors: amounts falling due within one year	18	(5,210,527)		(6,261,335)
Net current assets			564,321		480,610
Total assets less current liabilities			2,431,669		2,429,824
Creditors: amounts falling due after more than one year	19		(183,334)		(403,334)
Provisions for liabilities
Deferred taxation	22		(265,566)		(246,030)
Other provisions	23		(566,217)		(591,707)
Net assets			1,416,552		1,188,753

Capital and reserves
Called up share capital	24	110	110
Foreign exchange reserve	25	(15,061)	20,061
Profit and loss account	25	1,431,503	1,168,582
		1,416,552	1,188,753

Page 11

GLOBAL INFUSION GROUP LTD

REGISTERED NUMBER: 02634604

CONSOLIDATED STATEMENT OF FINANCIAL POSITION (CONTINUED)

AS AT 31 DECEMBER 2024

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 27 August 2025.

S L May

Director

The notes on pages 20 to 42 form part of these financial statements.

Page 12

GLOBAL INFUSION GROUP LTD

REGISTERED NUMBER: 02634604

COMPANY STATEMENT OF FINANCIAL POSITION

AS AT 31 DECEMBER 2024

		31 December		30 June
		2024		2024
Note	£	£	£	£

Fixed assets
Intangible assets	12		15,746		18,711
Tangible assets	13		1,845,379		1,922,928
Investments	14		937		108
			1,862,062		1,941,747
Current assets
Stocks	15	-		79,174
Debtors: amounts falling due within one year	16	3,612,214		4,340,899
Cash at bank and in hand	17	1,849,788		1,956,756
		5,462,002		6,376,829
Creditors: amounts falling due within one year	18	(5,566,047)		(6,469,258)
Net current liabilities			(104,045)		(92,429)
Total assets less current liabilities			1,758,017		1,849,318

Creditors: amounts falling due after more than one year	19		(183,334)		(403,334)
Provisions for liabilities
Deferred taxation	22		(265,566)		(246,030)
Other provisions	23		(566,217)		(591,707)
Net assets			742,900		608,247

Capital and reserves
Called up share capital	24		110		110
Profit and loss account brought forward		608,137		458,487
Profit for the period		134,653		149,650
Profit and loss account carried forward			742,790		608,137
			742,900		608,247

Page 13

GLOBAL INFUSION GROUP LTD

REGISTERED NUMBER: 02634604

COMPANY STATEMENT OF FINANCIAL POSITION (CONTINUED)

AS AT 31 DECEMBER 2024

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 27 August 2025.

S L May

Director

The notes on pages 20 to 42 form part of these financial statements.

Page 14

GLOBAL INFUSION GROUP LTD

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

FOR THE PERIOD ENDED 31 DECEMBER 2024

	Called up share capital	Foreign exchange reserve	Profit and loss account	Total equity
	£	£	£	£
At 1 July 2024	110	20,061	1,168,582	1,188,753
Comprehensive income for the period
Profit for the period	-	-	262,921	262,921
Movement on foreign exchange	-	(35,122)	-	(35,122)
Total comprehensive income for the period	-	(35,122)	262,921	227,799
Total transactions with owners	-	-	-	-
At 31 December 2024	110	(15,061)	1,431,503	1,416,552

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

FOR THE YEAR ENDED 30 JUNE 2024

	Called up share capital	Foreign exchange reserve	Profit and loss account	Total equity
	£	£	£	£
At 1 July 2023	110	8,747	929,415	938,272
Comprehensive income for the year
Profit for the year	-	-	239,167	239,167
Movement on foreign exchange	-	11,314	-	11,314
Total comprehensive income for the year	-	11,314	239,167	250,481
Total transactions with owners	-	-	-	-
At 30 June 2024	110	20,061	1,168,582	1,188,753

The notes on pages 20 to 42 form part of these financial statements.

Page 15

GLOBAL INFUSION GROUP LTD

COMPANY STATEMENT OF CHANGES IN EQUITY

FOR THE PERIOD ENDED 31 DECEMBER 2024

	Called up share capital	Profit and loss account	Total equity
	£	£	£
At 1 July 2024	110	608,137	608,247
Comprehensive income for the year
Profit for the period	-	134,653	134,653
Total comprehensive income for the period	-	134,653	134,653
Total transactions with owners	-	-	-
At 31 December 2024	110	742,790	742,900

COMPANY STATEMENT OF CHANGES IN EQUITY

FOR THE YEAR ENDED 30 JUNE 2024

	Called up share capital	Profit and loss account	Total equity
	£	£	£
At 1 July 2023	110	458,487	458,597
Comprehensive income for the year
Profit for the year	-	149,650	149,650
Total comprehensive income for the year	-	149,650	149,650
Total transactions with owners	-	-	-
At 30 June 2024	110	608,137	608,247

The notes on pages 20 to 42 form part of these financial statements.

Page 16

GLOBAL INFUSION GROUP LTD

CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE PERIOD ENDED 31 DECEMBER 2024

			Period ended 31 December	Year ended 30 June
			2024	2024
			£	£

Cash flows from operating activities
Profit for the financial period	262,921	239,167
Adjustments for:
Amortisation of intangible assets	2,965	2,965
Depreciation of tangible assets	176,159	302,398
Interest payable	34,190	78,967
Interest received	(5,287)	(11,723)
Taxation charge	154,869	189,886
Decrease/(increase) in stocks	79,174	(52,319)
Decrease in debtors	851,595	618,098
(Decrease)/increase in creditors	(1,089,557)	170,850
(Decrease) in amounts owed to connected parties	(60,000)	(158,620)
(Decrease)/increase in provisions	(25,490)	87,000
Corporation tax (paid)	(36,584)	(211,890)
Movement on foreign exchange	35,122	11,314
Net cash generated from operating activities	380,077	1,266,093

Page 17

GLOBAL INFUSION GROUP LTD

CONSOLIDATED STATEMENT OF CASH FLOWS (CONTINUED)

FOR THE PERIOD ENDED 31 DECEMBER 2024

		31 December	30 June
		2024	2024
		£	£



Cash flows from investing activities
Purchase of tangible fixed assets	(97,258)	(342,375)
Interest received	5,287	11,723
Net cash used in investing activities	(91,971)	(330,652)
Cash flows from financing activities
Repayment of loans	(220,000)	(440,000)
Interest paid	(34,190)	(78,967)
Net cash used in financing activities	(254,190)	(518,967)
Net increase in cash and cash equivalents	33,916	416,474
Cash and cash equivalents at beginning of period	2,214,594	1,798,120
Cash and cash equivalents at the end of period	2,248,510	2,214,594

Cash and cash equivalents at the end of period comprise:
Cash at bank and in hand	2,248,510	2,214,594
	2,248,510	2,214,594

The notes on pages 20 to 42 form part of these financial statements.

Page 18

GLOBAL INFUSION GROUP LTD

CONSOLIDATED ANALYSIS OF NET DEBT

FOR THE PERIOD ENDED 31 DECEMBER 2024


At 1 July 2024	Cash flows	At 31 December 2024
£	£	£

Cash at bank and in hand	2,214,594	33,916	2,248,510
Debt due after 1 year	(403,334)	220,000	(183,334)
Debt due within 1 year	(440,000)	-	(440,000)
	1,371,260	253,916	1,625,176

The notes on pages 20 to 42 form part of these financial statements.

Page 19

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

1.	General information

Global Infusion Group Limited is a company limited by shares, incorporated in England and Wales. The address of the registered office is Unit 1 Symmetry Park, Samian Way, Aston Clinton, Bucks, HP22 5WJ.
The principal activity of the company and the group is that of providing on-site catering.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires Group management to exercise judgment in applying the Group's accounting policies (see note 3).

The Company has taken advantage of the exemption allowed under section 408 of the Companies Act 2006 and has not presented its own Statement of comprehensive income in these financial statements.

The following principal accounting policies have been applied:

2.2

Basis of consolidation and investments in subsidiaries

The consolidated financial statements incorporate the financial statements of the Company and entities controlled by the Group (its subsidiaries). Control is achieved where the group has the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities.
The consolidated financial statements incorporate the results of business combinations using the purchase method. In the balance sheet, the acquiree's identifiable assets, liabilities and contingent liabilities are initially recognised at their fair values at the acquisition date. The results of acquired operations are included in the consolidated statement of comprehensive income from the date on which control is obtained. They are deconsolidated from the date control ceases. All intra-group transactions, balances, income and expenses are eliminated in full on consolidation.

2.3

Going concern

The group is showing net assets of £1,447,607 which is a further improvement on prior period net assets of £1,188,753. The group had a successful year, achieving profit of £227,799 (30 June 2024 - £250,481) and has been profitable in the months following the year end. As such, the directors believe that there are no significant uncertainties in their assessment of whether the business is a going concern for a period of not less than 12 months from the date of signing of these financial statements. The directors have therefore prepared the accounts on a going concern basis.

Page 20

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Group and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

∙the amount of revenue can be measured reliably;

∙it is probable that the Group will receive the consideration due under the contract;

∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and

∙the costs incurred and the costs to complete the contract can be measured reliably.

Other revenue is recognised over the period in which the service is provided.

2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Leasehold land and buildings	-	Over length of the lease
Catering equipment	-	10-20% straight line
Plant and machinery	-	20% straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.
Assets under construction relates to assets that are in the course of construction and not yet in use by the group. The assets will be capitalised into their appropriate asset class as and when they are brought into use by the group. Assets under construction are not depreciated.

2.6

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Page 21

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

2.7

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.
At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in the Consolidated statement of comprehensive income.

2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

In the Consolidated statement of cash flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand and form an integral part of the Group's cash management.

2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 22

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

2.11

Foreign currency translation

Functional and presentation currency
The Group's functional and presentational currency is GBP.
Transactions and balances
Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.
At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.
Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.
On consolidation, the results of overseas operations are translated into Sterling at rates approximating to those ruling when the transactions took place. All assets and liabilities of overseas operations are translated at the rate ruling at the reporting date. Exchange differences arising on translating the opening net assets at opening rate and the results of overseas operations at actual rate are recognised in other comprehensive income.

2.12

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

2.13

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2.14

Operating leases: the Group as lessee

Rentals paid under operating leases are charged to the Consolidated statement of comprehensive income on a straight-line basis over the lease term.

Page 23

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

2.15

Pensions

Defined contribution pension plan

The Group operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Group pays fixed contributions into a separate entity. Once the contributions have been paid the Group has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Group in independently administered funds.

2.16

Interest income

Interest income is recognised in profit or loss using the effective interest method.

2.17

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

2.18

Current and deferred taxation

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company and the Group operate and generate income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:

∙The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits;

∙Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met; and

∙Where they relate to timing differences in respect of interests in subsidiaries, associates, branches and joint ventures and the Group can control the reversal of the timing differences and such reversal is not considered probable in the foreseeable future.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

Page 24

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

2.19

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

2.20

Impairment of fixed assets and goodwill

Assets that are subject to depreciation or amortisation are assessed at each reporting date to determine whether there is any indication that the assets are impaired. Where there is any indication that an asset may be impaired, the carrying value of the asset (or cash-generating unit to which the asset has been allocated) is tested for impairment. An impairment loss is recognised for the amount by which the asset's carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an asset's (or CGU's) fair value less costs to sell and value in use. For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows (CGUs). Non-financial assets that have been previously impaired are reviewed at each reporting date to assess whether there is any indication that the impairment losses recognised in prior periods may no longer exist or may have decreased.

3.	Judgments in applying accounting policies and key sources of estimation uncertainty

In preparing these financial statements, the director has had to make the following judgments in applying the above accounting policies that have had the most significant effect on the amounts recognised in the financial statements:
Determine whether leases entered into by the Group either as a lessor or a lessee are operating leases or finance leases. These decisions depend on an assessment of whether the risks and rewards of ownership have been transferred from the lessor to the lessee on a lease by lease basis.

Page 25

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

Turnover

The whole of the turnover is attributable to the group's principal activities.

Analysis of turnover by country of destination:

					Period ended 31 December	Year ended 30 June
					2024	2024
					£	£

United Kingdom	6,861,650	12,112,493
Rest of Europe	5,679,204	3,192,111
Rest of the world	336,671	403,718
	12,877,525	15,708,322

Depreciation of tangible fixed assets	176,159	302,398
Operating lease rentals - land and buildings	331,727	663,240
Exchange differences	58,692	(6,445)
Defined contribution pension cost	75,445	120,511
Amortisation	2,965	2,965

Fees payable to the Group's auditor for the audit of the Group's annual financial statements

19,030

19,025

Page 26

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024


Wages and salaries	1,533,302	2,675,189
Social security costs	154,323	194,834
Cost of defined contribution scheme	75,445	120,511
	1,763,070	2,990,534


Administration	29	28
Catering	15	15
Logistics and warehousing	26	31
	70	74

Page 27

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

Directors' emoluments	220,029	388,122
Group contributions to defined contribution pension schemes	17,004	10,833
	237,033	398,955

	During the period retirement benefits were accruing to 3 directors (Year ended 30 June 2024 - 3) in respect of defined contribution pension schemes.
	The highest paid director received remuneration of £93,834 (Year ended 30 June 2024 - £168,348).
	The value of the Group's contributions paid to a defined contribution pension scheme in respect of the highest paid director amounted to £4,999 (Year ended 30 June 2024 - £9,072).

	Other interest receivable	5,287	11,723
		5,287	11,723

	Bank interest payable	34,190	78,967
		34,190	78,967

Page 28

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

Corporation tax
Current tax on profits for the period	135,333	34,028
Adjustments in respect of previous periods	-	6,598
	135,333	40,626

Total current tax	135,333	40,626

Deferred tax
Origination and reversal of timing differences	19,536	149,260
Total deferred tax	19,536	149,260


	Tax on profit	154,869	189,886

Page 29

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

11.Taxation (continued)

Profit on ordinary activities before tax

417,790

429,053

Profit on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2024 - 25%)	104,448	110,092
Effects of:
Expenses not deductible for tax purposes, other than goodwill amortisation and impairment	2,496	7,011
Capital allowances for period/year in excess of depreciation	36,484	135,170
Utilisation of tax losses	-	(28,387)
Adjustments to tax charge in respect of prior periods	-	6,598
Other timing differences leading to an increase in taxation	11,441	(40,598)
Total tax charge for the period/year	154,869	189,886

Factors that may affect future tax charges

There are no other significant factors that may materially effect future tax charges.

Page 30

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

		Intangible assets
		£
	Cost
	At 1 July 2024	29,645
	At 31 December 2024	29,645
	Amortisation
	At 1 July 2024	10,934
	Charge for the period on owned assets	2,965
	At 31 December 2024	13,899
	Net book value
	At 31 December 2024	15,746
	At 30 June 2024	18,711

Page 31

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

12.Intangible assets (continued)

	Company

		Intangible assets
		£
	Cost
	At 1 July 2024	29,645
	At 31 December 2024	29,645
	Amortisation
	At 1 July 2024	10,934
	Charge for the year	2,965
	At 31 December 2024	13,899
	Net book value
	At 31 December 2024	15,746
	At 30 June 2024	18,711

Page 32

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

13.	Tangible fixed assets
	Group

	Land and buildings improvements	Other Fixed assets	Assets under construction	Total
	£	£	£	£
Cost
At 1 July 2024	1,995,189	3,683,232	40,657	5,719,078
Additions	65,100	32,158	-	97,258
Transfers between classes	34,621	(34,621)	-	-
At 31 December 2024	2,094,910	3,680,769	40,657	5,816,336
Depreciation
At 1 July 2024	533,234	3,255,341	-	3,788,575
Charge for the year	133,223	42,936	-	176,159
At 31 December 2024	666,457	3,298,277	-	3,964,734
Net book value
At 31 December 2024	1,428,453	382,492	40,657	1,851,602
At 30 June 2024	1,461,955	427,891	40,657	1,930,503

At 31 December 2024, land and buildings of £2,094,910 (30 June 2024 - £1,995,189) relates to short term leasehold property.

Page 33

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

13.Tangible fixed assets (continued)

	Company

	Land and buildings improvements	Other Fixed assets	Assets under construction	Total
	£	£	£	£
Cost
At 1 July 2024	1,995,189	3,670,244	40,657	5,706,090
Additions	65,100	32,158	-	97,258
Transfers between classes	34,621	(34,621)	-	-
At 31 December 2024	2,094,910	3,667,781	40,657	5,803,348
Depreciation
At 1 July 2024	533,234	3,249,928	-	3,783,162
Charge for the year	133,223	41,584	-	174,807
At 31 December 2024	666,457	3,291,512	-	3,957,969
Net book value
At 31 December 2024	1,428,453	376,269	40,657	1,845,379
At 30 June 2024	1,461,955	420,316	40,657	1,922,928

At 31 December 2024, land and buildings of £2,094,910 (30 June 2024 - £1,995,189) relates to short term leasehold property.

Page 34

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

14.	Fixed asset investments

	Company

		Investments in subsidiary companies
		£
	Cost or valuation
	At 1 July 2024	74,874
	Additions	829
	At 31 December 2024	75,703
	Impairment
	At 1 July 2024	74,766
	At 31 December 2024	74,766
	Net book value
	At 31 December 2024	937
	At 30 June 2024	108

Subsidiary undertakings
The following were subsidiary undertakings of the Company:
Name	Activity	Class of shares	Holding

e2b Logistics Limited	Dormant	Ordinary	100%
GIG Asia e2b Limited	Logistics	Ordinary	100%
Eat to the Beat Limited	Dormant	Ordinary	100%
Eat to the Beat Inc	Catering	Ordinary	100%
GIG HK Limited	Dormant	Ordinary	100%
Global Infusion Group France SAS	Catering	Ordinary	100%

GIG Asia e2b Limited is incorporated in China. GIG HK Limited is incorporated in Hong Kong. Eat to the Beat Inc., a company 100% owned by Eat to the Beat Ltd, is incorporated in the USA. Global Infusion Group France SAS is incorporated in France. The other subsidiaries are incorporated in the UK.

Page 35

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

15.	Stocks
		Group 31 December	Group 30 June	Company 31 December	Company 30 June
		2024	2024	2024	2024
		£	£	£	£

Finished goods and goods for resale	-	79,174	-	79,174
	-	79,174	-	79,174

16.

Debtors

Group 31 December	Group 30 June	Company 31 December	Company 30 June
2024	2024	2024	2024
£	£	£	£


Trade debtors	1,464,531	1,596,385	1,463,484	1,521,866
Amounts owed by group undertakings	-	-	187,512	3,426
Other debtors	211,860	211,126	111,271	197,383
Prepayments and accrued income	1,849,947	2,640,666	1,849,947	2,618,224
	3,526,338	4,448,177	3,612,214	4,340,899

17.	Cash and cash equivalents
		Group 31 December	Group 30 June	Company 31 December	Company 30 June
		2024	2024	2024	2024
		£	£	£	£

Cash at bank and in hand	2,248,510	2,214,594	1,849,788	1,956,756
	2,248,510	2,214,594	1,849,788	1,956,756

Page 36

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

18.	Creditors: Amounts falling due within one year
		Group 31 December	Group 30 June	Company 31 December	Company 30 June
		2024	2024	2024	2024
		£	£	£	£

Bank loans	440,000	440,000	440,000	440,000
Trade creditors	1,119,876	998,126	1,109,271	990,326
Amounts owed to group undertakings	-	-	413,691	312,796
Amounts owed to joint ventures	459,180	519,180	459,180	519,180
Corporation tax	128,390	29,641	95,035	29,641
Other taxation and social security	524,683	428,467	520,138	419,178
Other creditors	235,895	215,645	252,997	230,781
Accruals and deferred income	2,302,503	3,630,276	2,275,735	3,527,356
	5,210,527	6,261,335	5,566,047	6,469,258

Bank loans are secured by a fixed and floating charge over the group's assets.

19.	Creditors: Amounts falling due after more than one year
		Group 31 December	Group 30 June	Company 31 December	Company 30 June
		2024	2024	2024	2024
		£	£	£	£

Bank loans	183,334	403,334	183,334	403,334
	183,334	403,334	183,334	403,334

Bank loans are secured by a fixed and floating charge over the group's assets.

Page 37

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

20.	Loans
	Analysis of the maturity of loans is given below:
		Group 31 December	Group 30 June	Company 31 December	Company 30 June
		2024	2024	2024	2024
		£	£	£	£

Amounts falling due within one year
Bank loans	440,000	440,000	440,000	440,000
Amounts falling due 1-2 years
Bank loans	183,334	403,334	183,334	403,334
Amounts falling due 2-5 years
	623,334	843,334	623,334	843,334

21.	Financial instruments
		Group 31 December	Group 30 June	Company 31 December	Company 30 June
		2024	2024	2024	2024
		£	£	£	£

	Financial assets
	Financial assets that are debt instruments measured at amortised cost	1,676,211	1,807,511	1,762,267	1,722,675

	Financial liabilities
	Financial liabilities measured at amortised cost	2,438,285	2,576,285	2,858,473	2,896,417

Financial assets that are debt instruments measured at amortised cost comprise trade and other debtors, amounts due from group undertakings and amounts due from associated undertakings.
Financial liabilities measured at amortised cost comprise bank loans, trade and other creditors, amounts due to group undertakings and amounts due to and associated undertakings.

Page 38

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

22.	Deferred taxation
	Group

	31 December 2024	30 June 2024
	£	£

At beginning of period/year	246,030	96,770
Charged to the Statement of comprehensive income	19,536	149,260
At end of period/year	265,566	246,030

Company

	31 December 2024	30 June 2024
	£	£

At beginning of period/year	246,030	96,770
Charged to the Statement of comprehensive income	19,536	149,260
At end of period/year	265,566	246,030

Group 31 December	Group 30 June	Company 31 December	Company 30 June
2024	2024	2024	2024
£	£	£	£

	Accelerated capital allowances	265,566	246,030	265,566	246,030
		265,566	246,030	265,566	246,030

Page 39

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

23.	Provisions
	Group

		Provision
		£

	At 1 July 2024	591,707
	Charged to profit or loss	42,000
	Utilised in period	(67,490)
	At 31 December 2024	566,217

Company

	Provision	Total
	£	£

At 1 July 2024	591,707	591,707
Charged to profit or loss	42,000	42,000
Utilised in period	(67,490)	(67,490)
At 31 December 2024	566,217	566,217

The split of the provisions has not been given due to the ongoing and future discussions with the third parties and the potential prejudicial effect it would have on those negotiations.

Allotted, called up and fully paid

11,000 Ordinary A shares of £0.01 each	110	110

25.

Reserves

Foreign exchange reserve

Exchange gains and losses arising on the retranslation of foreign subsidiaries on consolidation.

Profit and loss account

Profit and loss account includes all current and prior period retained profits and losses.

Page 40

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

26.	Pension commitments

The group operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the group in an independently administered fund. The pension cost charge represents contributions payable by the group to the fund and amounted to £75,445 (year ended 30 June 2024 - £120,511). At the period end an amount of £3,603 (30 June 2024 - £39,090) was included within creditors in relation to outstanding pension costs still payable.

27.	Commitments under operating leases
	At 31 December 2024 the Group and the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:
		Group 31 December	Group 30 June	Company 31 December	Company 30 June
		2024	2024	2024	2024
		£	£	£	£


Not later than 1 year	649,690	649,690	649,690	649,690
Later than 1 year and not later than 5 years	2,598,761	2,598,761	2,598,761	2,598,761
Later than 5 years	3,140,170	3,465,015	3,140,170	3,465,015
	6,388,621	6,713,466	6,388,621	6,713,466

Group 31 December	Group 30 June	Company 31 December	Company 30 June
2024	2024	2024	2024
£	£	£	£

Not later than 1 year	43,587	76,940	43,587	76,940
Later than 1 year and not later than 5 years	-	12,418	-	12,418
	43,587	89,358	43,587	89,358

28.	Transactions with directors

During the year, the company made loans to directors. An amount of £16,170 (year ended 30 June 2024 - £917) was advanced and £19,982 (year ended 30 June 2024 - £159,420) was repaid. At the period end, the company was owed an amount of £8,157 (year ended 30 June 2024 - £4,345). No interest is accruing on the loans.

Page 41

GLOBAL INFUSION GROUP LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

29.

Related party transactions

The company has taken advantage of the exemption allowed by Financial Reporting Standard 102, not to disclose any transactions between the parent company and other wholly owned subsidiaries.

As at 31 December 2024, the group owed £459,180 (30 June 2024 - £519,180) to a partnership of which the company is a member.

At 31 December 2024, the group had loans to and from an Employee Benefit Trust which is controlled by the directors. At the end of the period (30 June 2024 - year), the balance owed from the trust amounted to £299,089 (30 June 2024 - £299,089), which was included in prepayments and the amount owed to the trust amounted to £299,206 (30 June 2024 - £299,206), which was included in other creditors. The interest charged to the group on the outstanding balance amounted to £Nil (year ended 30 June 2024 - £Nil).

Key management compensation for the period was £317,858 (year ended 30 June 2024 - £582,395).

30.	Controlling party

The ultimate controlling party of the group are the directors.

Page 42